FSA
WINT

Franklin Street Advisors’s Windtree Therapeutics Inc WINT Stock Holding History

Franklin Street Advisors’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-3,214
Closed -$52K – 223
2014
Q4 		$52K Hold
3,214
– – 0.01% 202
2014
Q3 		$83K Sell
3,214
-107
-3% -$2.58K 0.02% 220
2014
Q2 		$83K Hold
3,321
– – 0.02% 219
2014
Q1 		$100K Hold
3,321
– – 0.02% 216
2013
Q4 		$105K Hold
3,321
– – 0.02% 219
2013
Q3 		$91K Sell
3,321
-381
-10% -$9.23K 0.02% 222
2013
Q2 		$79K Buy
+3,702
New +$91.2K 0.02% 230

Other funds holding WINT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Franklin Street Advisors's WINT Position: Q1 2015 in Review

Franklin Street Advisors sold out of Windtree Therapeutics Inc (WINT) in Q1 2015, closing a stake of 3,214 shares — an estimated $52K sold.

Franklin Street Advisors first reported a position in WINT in Q2 2013 and held it in 7 quarters. The position peaked at $105K in Q4 2013. 58 funds tracked by Wall St. Rank hold WINT as of Q1 2015.

  • Franklin Street Advisors reported no remaining Windtree Therapeutics Inc position as of Q1 2015 after selling out during the quarter.
  • Franklin Street Advisors sold 3,214 Windtree Therapeutics Inc shares in Q1 2015, an estimated $52K.
  • Franklin Street Advisors first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 7 quarters.
  • Franklin Street Advisors's Windtree Therapeutics Inc position peaked at $105K in Q4 2013.
  • 58 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q1 2015.

Based on Franklin Street Advisors's 13F filing for Q1 2015, filed 8 Apr 2015.